Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis
- PMID: 21734128
- PMCID: PMC3122347
- DOI: 10.4269/ajtmh.2011.10-0680
Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis
Abstract
Cutaneous leishmaniasis (CL) is a worldwide disease endemic in several regions of the globe. The hallmark of CL is skin ulcers likely driven by efforts of the immune system to control Leishmania growth. Cytokines, such as tumor necrosis factor (TNF) and interferon-gamma can control disease progression in animal models. Nevertheless, the impact of these cytokines in CL ulcer outcome is not well established in humans. In this study, 96 CL patients from an endemic area of Leishmania braziliensis were enrolled for a follow-up study that consisted of clinical and immunological evaluations in a 2-year period. Statistical analysis revealed that healing time (P = 0.029), age (P = 0.002), and TNF levels (P = 0.0002) positively correlate with ulcer size at the time of the first clinical evaluation. Our findings suggest that ulcer size correlates with healing time and TNF levels support the use of TNF inhibitors combined with standard therapy to improve healing in CL patients with severe lesions.
Figures



Similar articles
-
CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.Clin Exp Immunol. 2011 Sep;165(3):338-51. doi: 10.1111/j.1365-2249.2011.04430.x. Epub 2011 Jul 4. Clin Exp Immunol. 2011. PMID: 21726211 Free PMC article.
-
Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.Infect Immun. 2015 Mar;83(3):898-906. doi: 10.1128/IAI.02404-14. Epub 2014 Dec 22. Infect Immun. 2015. PMID: 25534940 Free PMC article.
-
Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production.BMC Infect Dis. 2006 Apr 25;6:75. doi: 10.1186/1471-2334-6-75. BMC Infect Dis. 2006. PMID: 16638143 Free PMC article.
-
Tissue damage and immunity in cutaneous leishmaniasis.Parasite Immunol. 2012 Dec;34(12):551-61. doi: 10.1111/pim.12007. Parasite Immunol. 2012. PMID: 23009296 Review.
-
PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3258. doi: 10.1371/journal.pntd.0003258. eCollection 2014. PLoS Negl Trop Dis. 2014. PMID: 25412435 Free PMC article. Review.
Cited by
-
Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.Pathog Glob Health. 2016 Sep;110(6):247-260. doi: 10.1080/20477724.2016.1232042. Epub 2016 Sep 23. Pathog Glob Health. 2016. PMID: 27660895 Free PMC article. Review.
-
Review on the Role of Host Immune Response in Protection and Immunopathogenesis during Cutaneous Leishmaniasis Infection.J Immunol Res. 2020 Jun 18;2020:2496713. doi: 10.1155/2020/2496713. eCollection 2020. J Immunol Res. 2020. PMID: 32656269 Free PMC article. Review.
-
Leishmania major-Infected Phlebotomus duboscqi Sand Fly Bites Enhance Mast Cell Degranulation.Pathogens. 2023 Jan 28;12(2):207. doi: 10.3390/pathogens12020207. Pathogens. 2023. PMID: 36839479 Free PMC article.
-
Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection.PLoS Pathog. 2014 Feb 27;10(2):e1003970. doi: 10.1371/journal.ppat.1003970. eCollection 2014 Feb. PLoS Pathog. 2014. PMID: 24586170 Free PMC article.
-
The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis.Front Public Health. 2014 Sep 29;2:165. doi: 10.3389/fpubh.2014.00165. eCollection 2014. Front Public Health. 2014. PMID: 25325049 Free PMC article. Review.
References
-
- Oliveira JG, Novais FO, de Oliveira CI, da Cruz Junior AC, Campos LF, da Rocha AV, Boaventura V, Noronha A, Costa JM, Barral A. Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis. Acta Trop. 2005;94:55–59. - PubMed
-
- Rosa AC, Cuba CC, Vexenat A, Barreto AC, Marsden PD. Predominance of Leishmania braziliensis braziliensis in the regions of Tres Bracos and Corte de Pedra, Bahia, Brazil. Trans R Soc Trop Med Hyg. 1988;82:409–410. - PubMed
-
- Barral A, Guerreiro J, Bomfim G, Correia D, Barral-Netto M, Carvalho EM. Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis. Am J Trop Med Hyg. 1995;53:256–259. - PubMed
-
- Gaafar A, Veress B, Permin H, Kharazmi A, Theander TG, el Hassan AM. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major. Clin Immunol. 1999;91:314–320. - PubMed
-
- Pompeu MM, Brodskyn C, Teixeira MJ, Clarencio J, Van Weyenberg J, Coelho IC, Cardoso SA, Barral A, Barral-Netto M. Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers. Infect Immun. 2001;69:7453–7460. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources